Ocuphire Pharma (Ocup) Appoints George Magrath As CEO

Nov 01, 2023•almost 2 years ago

Position

Chief Executive Officer

Company

Ocuphire Pharma

George Magrath

Farmington HillsPharmaceutical Manufacturing

Description

Ocuphire Pharma, Inc. , a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing small-molecule therapies for the treatment of retinal and refractive eye disorders, today announced the appointment of George Magrath, M.D., M.B.A., M.S., as Chief Executive Officer and member of the Board of Directors, effective today. Dr. Magrath succeeds Rick Rodgers, M.B.A., Interim Chief Executive Officer and President since April 2023

Company Information

Company

Ocuphire Pharma

Location

Farmington Hills, Michigan, United States

About

We are a late-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for retinal and refractive disorders. Ocuphire’s pipeline currently includes two small-molecule product candidates targeting significant unmet needs.

Related People

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months